69 related articles for article (PubMed ID: 18759047)
1. The thermodynamic stability of insulin disulfides is not affected by the C-domain of insulin-like growth factor 1.
Guo Z; Feng Y
Sci China C Life Sci; 2002 Jun; 45(3):245-50. PubMed ID: 18759047
[TBL] [Abstract][Full Text] [Related]
2. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
Guo ZY; Shen L; Feng YM
Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349
[TBL] [Abstract][Full Text] [Related]
3. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
Chen Y; You Y; Jin R; Guo ZY; Feng YM
Biochemistry; 2004 Jul; 43(28):9225-33. PubMed ID: 15248780
[TBL] [Abstract][Full Text] [Related]
4. The sequence determinant causing different folding behaviors of insulin and insulin-like growth factor-1.
Huang QL; Zhao J; Tang YH; Shao SQ; Xu GJ; Feng YM
Biochemistry; 2007 Jan; 46(1):218-24. PubMed ID: 17198392
[TBL] [Abstract][Full Text] [Related]
5. The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
Guo ZY; Shen L; Feng YM
Biochemistry; 2002 Aug; 41(34):10585-92. PubMed ID: 12186542
[TBL] [Abstract][Full Text] [Related]
6. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM
Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310
[TBL] [Abstract][Full Text] [Related]
7. Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway.
Miller JA; Narhi LO; Hua QX; Rosenfeld R; Arakawa T; Rohde M; Prestrelski S; Lauren S; Stoney KS; Tsai L
Biochemistry; 1993 May; 32(19):5203-13. PubMed ID: 8494897
[TBL] [Abstract][Full Text] [Related]
8. 1.42A crystal structure of mini-IGF-1(2): an analysis of the disulfide isomerization property and receptor binding property of IGF-1 based on the three-dimensional structure.
Yun CH; Tang YH; Feng YM; An XM; Chang WR; Liang DC
Biochem Biophys Res Commun; 2005 Jan; 326(1):52-9. PubMed ID: 15567151
[TBL] [Abstract][Full Text] [Related]
9. Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein.
Hober S; Hansson A; Uhlén M; Nilsson B
Biochemistry; 1994 Jun; 33(22):6758-61. PubMed ID: 7515683
[TBL] [Abstract][Full Text] [Related]
10. Unfolding of Recombinant Single-chain Insulin in Denaturants Containing Thiol Reagents.
Guo ZY; Qiao ZS; Feng YM
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2001; 33(4):431-436. PubMed ID: 12040418
[TBL] [Abstract][Full Text] [Related]
11. Peptide models of four possible insulin folding intermediates with two disulfides.
Jia XY; Guo ZY; Wang Y; Xu Y; Duan SS; Feng YM
Protein Sci; 2003 Nov; 12(11):2412-9. PubMed ID: 14573855
[TBL] [Abstract][Full Text] [Related]
12. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro.
Hober S; Uhlén M; Nilsson B
Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671
[TBL] [Abstract][Full Text] [Related]
13. Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family.
Sohma Y; Hua QX; Liu M; Phillips NB; Hu SQ; Whittaker J; Whittaker LJ; Ng A; Roberts CT; Arvan P; Kent SB; Weiss MA
J Biol Chem; 2010 Feb; 285(7):5040-55. PubMed ID: 19959476
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
[TBL] [Abstract][Full Text] [Related]
15. Studies on insulin/IGF-1 hybrid and IGF-1 growth-promoting functional region.
Wang P; Cai RR; Feng YM; Zhang YS
IUBMB Life; 2000 Apr; 49(4):321-5. PubMed ID: 10995036
[TBL] [Abstract][Full Text] [Related]
16. Probing the disulfide folding pathway of insulin-like growth factor-I.
Milner SJ; Carver JA; Ballard FJ; Francis GL
Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the residue Glu9, Glu46, and Phe49 to the biological activity of insulin-like growth factor-1.
Chen H; Feng YM
IUBMB Life; 2001 Jan; 51(1):33-7. PubMed ID: 11419693
[TBL] [Abstract][Full Text] [Related]
18. The in vitro oxidative folding of the insulin superfamily.
Guo ZY; Qiao ZS; Feng YM
Antioxid Redox Signal; 2008 Jan; 10(1):127-39. PubMed ID: 18004974
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
20. A peptide model of insulin folding intermediate with one disulfide.
Yan H; Guo ZY; Gong XW; Xi D; Feng YM
Protein Sci; 2003 Apr; 12(4):768-75. PubMed ID: 12649435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
